These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6114930)

  • 41. Pharmacokinetics of oxprenolol in normal subjects.
    Mason WD; Winer N
    Clin Pharmacol Ther; 1976 Oct; 20(4):401-12. PubMed ID: 10124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma concentration and antihypertensive effect of beta-receptor blockers.
    Hitzenberger G
    Cardiology; 1979; 64 Suppl 1():14-9. PubMed ID: 42485
    [No Abstract]   [Full Text] [Related]  

  • 43. Beta-adrenoceptor blockers and the blood-brian barrier.
    Neil-Dwyer G; Bartlett J; McAinsh J; Cruickshank JM
    Br J Clin Pharmacol; 1981 Jun; 11(6):549-53. PubMed ID: 6115665
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction of cimetidine with metoprolol, propranolol, or atenolol.
    Kirch W; Köhler H; Spahn H; Mutschler E
    Lancet; 1981 Sep; 2(8245):531-2. PubMed ID: 6115283
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacokinetics of beta-receptor-blocking agents in relation to their anti-hypertensive effect.
    Gugler R; Bodem G; Dengler HJ
    Clin Sci Mol Med Suppl; 1976 Dec; 3():473s-475s. PubMed ID: 15758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Propranolol and metoprolol: Two comparable drugs with very different post-mortem toxicological profiles.
    Kriikku P; Pelkonen S; Kaukonen M; Ojanperä I
    Forensic Sci Int; 2021 Oct; 327():110978. PubMed ID: 34481114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of continuous ambulatory peritoneal dialysis on serum alpha 1-acid glycoprotein concentration and drug binding.
    Belpaire FM; Van de Velde EJ; Fraeyman NH; Bogaert MG; Lameire N
    Eur J Clin Pharmacol; 1988; 35(4):339-43. PubMed ID: 3197741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative study of various beta-adrenergic blockers in clinical anesthesiology--alprenolol, oxprenolol, propranolol and LB-46].
    Miyazaki M; Fujita T
    Masui; 1972 Jan; 21(1):1-10. PubMed ID: 4401934
    [No Abstract]   [Full Text] [Related]  

  • 49. Absence of DNA damage in mice and rats given high doses of five beta-adrenergic blocking agents.
    Maura A; Carlo P; Ricci R; Cavanna M; Brambilla G
    Arzneimittelforschung; 1985; 35(8):1236-8. PubMed ID: 2866775
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Side-effects of beta-adrenoceptor blocking drugs assessed by visual analogue scales.
    Lewis RV; Jackson PR; Ramsay LE
    Br J Clin Pharmacol; 1985 Feb; 19(2):255-7. PubMed ID: 2859044
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhancement of the bioavailability of propranolol and metoprolol by food.
    Melander A; Danielson K; Scherstén B; Wåhlin E
    Clin Pharmacol Ther; 1977 Jul; 22(1):108-12. PubMed ID: 872491
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A method for the assay of alpha 1-acid glycoprotein in dog serum and its application to the plasma binding of propranolol and oxprenolol in animals receiving rifampicin.
    Delcroix C; Fraeyman N; Belpaire F
    J Pharmacol Methods; 1984 Sep; 12(2):97-105. PubMed ID: 6536820
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exercise increases plasma concentrations of (R)- and (S)-propranolol.
    Stoschitzky K; Schumacher M; Stark G; Dimai HP; Stauber R; Stoschitzky P; Krejs GJ; Klein W; Lindner W
    Eur J Clin Pharmacol; 1996; 50(4):339-42. PubMed ID: 8803530
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 8. Self-poisoning with beta-adrenoceptor blocking agents: recognition and management.
    Frishman W; Jacob H; Eisenberg E; Ribner H
    Am Heart J; 1979 Dec; 98(6):798-811. PubMed ID: 40429
    [No Abstract]   [Full Text] [Related]  

  • 55. Plasma propranolol concentrations and the erythrocyte sedimentation rate.
    Schneider RE; Bishop H; Hawkins CF
    Br J Clin Pharmacol; 1979 Jul; 8(1):43-7. PubMed ID: 552296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tissue distribution of basic drugs: accounting for enantiomeric, compound and regional differences amongst beta-blocking drugs in rat.
    Rodgers T; Leahy D; Rowland M
    J Pharm Sci; 2005 Jun; 94(6):1237-48. PubMed ID: 15858851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interference of beta-blocking drugs with cortisol determinations.
    Radó JP; Végh L
    Int J Clin Pharmacol Biopharm; 1977 Jan; 15(1):5-6. PubMed ID: 14077
    [No Abstract]   [Full Text] [Related]  

  • 58. Variability of beta-blocker pharmacokinetics in young volunteers.
    Jack DB; Quarterman CP; Zaman R; Kendall MJ
    Eur J Clin Pharmacol; 1982; 23(1):37-42. PubMed ID: 6127220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The surface activity and self-association of some beta-adrenoceptor blocking agents in aqueous solution.
    Attwood D; Agarwal SP
    J Pharm Pharmacol; 1979 Jun; 31(6):392-5. PubMed ID: 39139
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents [proceedings].
    Bishop H; Kendall MJ; Quarterman CP; Schneider RE
    Br J Clin Pharmacol; 1980 Jan; 9(1):108P-109P. PubMed ID: 6101953
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.